Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Direxion Daily Real Estate Bull 3X Shares ETF
DRN
4
The Technology Select Sector SPDR® Fund
XLK
5
Direxion Daily Financial Bull 3X Shares ETF
FAS
US Stock MarketDetailed Quotes
Icecure Medical (ICCM)
- 0.3013
- +0.0153+5.35%
Close May 1 16:00 ET
- 0.3125
- +0.0112+3.72%
Post 18:50 ET
24.46MMarket Cap-1.26P/E (TTM)
0.3267High0.2902Low518.31KVolume0.2990Open0.2860Prev Close159.62KTurnover1.18%Turnover RatioLossP/E (Static)81.18MShares1.400052wk High2.71P/B13.19MFloat Cap0.252552wk Low--Dividend TTM43.78MShs Float16.0000Historical High--Div Yield TTM12.76%Range %0.2525Historical Low0.3080Avg Price1Lot Size
ICCM Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
ICCM Orderflow
Unit: --
ICCM Orderflow Trend
IntradayDayWeekMonth
No Data
Icecure Medical (ICCM) News
IceCure Medical Calls May 11 Special Meeting to Approve Potential Reverse Share Split
IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025
IceCure Medical Files to Sell 16M Ordinary Share for Holders
12 Health Care Stocks Moving In Monday's Intraday Session
Icecure Medical | 6-K: Report of foreign private issuer (related to financial reporting)
12 Health Care Stocks Moving In Thursday's Intraday Session
Icecure Medical (ICCM) Stock Forum
$Icecure Medical (ICCM.US)$ go to delist ?
2
2
$Icecure Medical (ICCM.US)$ such incompetent people on the top !
1
$Icecure Medical (ICCM.US)$ why drop dip, go to delisted ?
$Icecure Medical (ICCM.US)$
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
IceCure Medical Logo
NEWS PROVIDED BY
IceCure Medical
Mar 25, 2026, 08:30 ET
At a median follow-up of four years, 89.4% recurrence-free rate in patients with tumors ≤3 cm and no prior kidney cancer; 83.9% recurrence-free rate for general study population
Full analysis of results to be presented at European Conference of Intervent...
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
IceCure Medical Logo
NEWS PROVIDED BY
IceCure Medical
Mar 25, 2026, 08:30 ET
At a median follow-up of four years, 89.4% recurrence-free rate in patients with tumors ≤3 cm and no prior kidney cancer; 83.9% recurrence-free rate for general study population
Full analysis of results to be presented at European Conference of Intervent...
3
$Icecure Medical (ICCM.US)$ 0.67🤔🤔🤔🤔
1
1
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
105992747 : they going to do a meeting for stock split decision I think...no idea what's the minimum value a stock should have to have regulatory compliance !
105992747 105992747 : reverse split ! a 10:1 should make it above 2.5 I think...with current values 15:1 should be safer !